NIH Director Bhattacharya Pledges Full Budget Spend Despite Grant Award Delays
Despite a significant slowdown in awarding research grants, National Institutes of Health (NIH) Director Jay Bhattacharya has assured a House Appropriations subcommittee that the agency will spend its entire $48.7 billion budget by the complete of the 2026 fiscal year. This commitment comes amid concerns that unspent funds could be returned to the treasury.
Grant Award Lag Raises Concerns
According to an analysis by researchers at Johns Hopkins University, the NIH has awarded 74% fewer competitive grants – those funding new research projects – compared to the average rate during the same period from 2021 to 2024. This substantial lag sparked worries about the agency’s ability to fully utilize its allocated funds.
Bhattacharya’s Reassurance to Congress
During an oversight hearing before the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, Bhattacharya repeatedly stated the NIH’s intention to fully expend its budget. He addressed concerns about potential returned funds, emphasizing the agency’s commitment to supporting vital research.
Background on Jay Bhattacharya
Jayanta Bhattacharya, born in 1968, is an American health economist, and physician. He was appointed as the 18th Director of the National Institutes of Health in April 2025 by President Donald Trump and confirmed by the Senate in March 2025. Bhattacharya is the first Indian American to lead the NIH. He concurrently serves as the acting director of the Centers for Disease Control and Prevention, beginning in February 2026. Prior to leading the NIH, Bhattacharya was a professor of medicine, economics, and health research policy at Stanford University, and is now an emeritus professor. He earned his M.D. And Ph.D. In economics from Stanford University. He is known for his opposition to lockdowns and mask mandates implemented in response to the COVID-19 pandemic.
Looking Ahead
The NIH’s ability to accelerate grant awards in the coming months will be closely watched by the research community. Successfully spending the full budget is crucial for maintaining the momentum of biomedical research and addressing critical public health challenges.